Shanghai Micurx Pharmaceutical Co. Ltd. A

MicuRx: 15 Clinical and Preclinical Research Studies to be Presented at ESCMID Global 2025

MicuRx Pharmaceutical: Contezolid Global Phase III Clinical Trial Safety and Efficacy Evaluation Endorsed by Data Monitoring Committee, Promising Prospects for Diabetic Foot Infection Treatment